HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yariv Gerber Selected Research

Biomarkers (Surrogate Marker)

10/2017Contemporary Risk Stratification After Myocardial Infarction in the Community: Performance of Scores and Incremental Value of Soluble Suppression of Tumorigenicity-2.
9/2009Prognostic value of biomarkers in heart failure: application of novel methods in the community.
11/2006Lipoprotein-associated phospholipase A2 and prognosis after myocardial infarction in the community.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yariv Gerber Research Topics

Disease

9Myocardial Infarction
12/2020 - 11/2006
6Heart Failure
08/2015 - 08/2007
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 06/2005
4Frailty
01/2019 - 07/2013
4Neoplasms (Cancer)
01/2019 - 01/2017
4Cardiovascular Diseases (Cardiovascular Disease)
10/2013 - 11/2002
3Coronary Disease (Coronary Heart Disease)
05/2020 - 07/2002
3Hypertension (High Blood Pressure)
10/2009 - 04/2006
2Hemorrhage
01/2020 - 01/2019
2Infarction (Infarctions)
01/2019 - 10/2009
2Atherosclerosis
10/2008 - 10/2003
1Cognitive Dysfunction
01/2019
1Hypertriglyceridemia
01/2019
1Non-ST Elevated Myocardial Infarction
10/2017
1ST Elevation Myocardial Infarction
10/2017
1Fibrosis (Cirrhosis)
10/2017
1Amyloidosis
08/2015
1Weight Loss (Weight Reduction)
10/2013
1Inflammation (Inflammations)
10/2008
1Fatty Liver
10/2008
1Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
07/2008
1Type 2 Diabetes Mellitus (MODY)
10/2007
1Lung Diseases (Lung Disease)
08/2007
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
08/2007
1Obesity
04/2006
1Stroke (Strokes)
04/2006
1Dyslipidemias (Dyslipidemia)
04/2006
1Myocardial Ischemia (Ischemic Heart Diseases)
06/2005
1Sclerosis
10/2003

Drug/Important Bio-Agent (IBA)

3LipidsIBA
01/2019 - 11/2002
3Biomarkers (Surrogate Marker)IBA
10/2017 - 11/2006
3CholesterolIBA
10/2009 - 06/2005
2Nitrogen OxidesIBA
05/2020 - 01/2017
22'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2020 - 01/2019
2Particulate MatterIBA
10/2013 - 07/2013
21-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
04/2009 - 11/2006
2Apolipoprotein C-II (ApoC2)IBA
11/2002 - 07/2002
1Vehicle Emissions (Emissions, Vehicle)IBA
05/2020
1Pharmaceutical PreparationsIBA
01/2019
1MicronutrientsIBA
01/2019
1Fibrinogen (Factor I)FDA Link
01/2019
1BezafibrateIBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Biological ProductsIBA
10/2013
1Indicators and Reagents (Reagents)IBA
10/2013
1Troponin T (Troponin T1)IBA
03/2012
1TroponinIBA
02/2010
1Creatine Kinase (Creatine Phosphokinase)IBA
02/2010
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2008
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2008
1PowdersIBA
10/2008
1LDL Receptors (LDL Receptor)IBA
10/2008
1Messenger RNA (mRNA)IBA
10/2008
1beta Carotene (Betacarotene)FDA Link
10/2008
1Ointments (Pastes)IBA
07/2008
1Tacrolimus (Prograf)FDA LinkGeneric
07/2008
1Glucose (Dextrose)FDA LinkGeneric
10/2007
1CreatinineIBA
08/2007
1Uric Acid (Urate)IBA
04/2006
1LDL Lipoproteins (beta Lipoproteins)IBA
06/2005
1Triglycerides (Triacylglycerol)IBA
10/2003
1Lipoproteins (Lipoprotein)IBA
10/2003
1Apolipoproteins C (ApoC)IBA
11/2002

Therapy/Procedure

3Secondary Prevention
12/2020 - 11/2008
3Percutaneous Coronary Intervention
01/2019 - 01/2018
2Therapeutics
01/2019 - 08/2015
2Cardiac Rehabilitation
02/2011 - 10/2009
1Transplantation
08/2015
1Institutionalization (Institutionalized Persons)
06/2014